Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
SC TO-T/AAmendment to a previously filed SC TO-TDec 31, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-T/AAmendment to a previously filed SC TO-TDec 24, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-TTender offer schedule and amendment filed by a third party.Dec 12, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coDec 10, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coDec 10, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coDec 1, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 26, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 25, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 24, 2014View HTMLDownload DOCDownload PDFDownload XLS
SC TO-CWritten public communication relating to an issuer or third party tender offer not by the subject coNov 24, 2014View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information